| 3种治疗急性缺血性脑卒中药的最小成本分析 |
| |
| 引用本文： | 吴玉波,王伟巍,李岩,张卓伯,蒋爱华,马丽颖,徐艳丽,孙向菊,闫虹. 3种治疗急性缺血性脑卒中药的最小成本分析[J]. 中国药房, 2011, 0(10): 865-866 |
| |
| 作者姓名： | 吴玉波 王伟巍 李岩 张卓伯 蒋爱华 马丽颖 徐艳丽 孙向菊 闫虹 |
| |
| 作者单位： | 哈尔滨医科大学附属第四医院药学部; |
| |
| 摘 要： | 目的:对3种治疗急性缺血性脑卒中药进行药物经济学评价。方法:95例急性缺血性脑卒中患者按照不同药物治疗方案分为3组,分别给予巴曲酶(降纤组)、阿加曲班(抗凝组)、阿替普酶(溶栓组)治疗,进行最小成本分析。结果:降纤组、抗凝组、溶栓组的总有效率分别为88.89%、85.00%、94.74%(P>0.05),人均治疗总成本分别为13098.27、15477.96、21040.86元(P<0.05)。结论:降纤组方案较经济。
|
| 关 键 词： | 急性缺血性脑卒中 最小成本分析 巴曲酶 阿加曲班 阿替普酶 |
Cost-minimization Analysis of 3 Types of Drugs for Acute Ischemic Stroke |
| |
| WU Yu-bo,WANG Wei-wei,LI Yan,ZHANG Zhuo-bo,JIANG Ai-hua,MA Li-ying,XU Yan-li,SUN Xiang-ju,YAN Hong. Cost-minimization Analysis of 3 Types of Drugs for Acute Ischemic Stroke[J]. China Pharmacy, 2011, 0(10): 865-866 |
| |
| Authors: | WU Yu-bo WANG Wei-wei LI Yan ZHANG Zhuo-bo JIANG Ai-hua MA Li-ying XU Yan-li SUN Xiang-ju YAN Hong |
| |
| Affiliation: | WU Yu-bo,WANG Wei-wei,LI Yan,ZHANG Zhuo-bo,JIANG Ai-hua,MA Li-ying,XU Yan-li,SUN Xiang-ju,YAN Hong(Dept.of Pharmacy,Forth Affiliated Hospital of Harbin Medical University,Harbin 150001,China) |
| |
| Abstract: | OBJECTIVE:To evaluate the pharmacoeconomic efficacy of 3 types of drugs for acute ischemic stroke.METHODS:95 patients with acute ischemic stroke were administered with batroxobin(defibrase group),argatroba(anticoagulant group),alteplase(thrombolysis group).Cost-minimization analysis was applied to analyze the therapeutic effects and costs.RESULTS:The total costs of 3 groups were 13 098.27 yuan,15 477.96 yuan and 21 040.86 yuan,respectively(P<0.05).The total effective rates were 88.89%,85.00% and 94.74%(P>0.... |
| |
| Keywords: | Acute ischemic stroke Cost-minimization analysis Batroxobin Argatroban Alteplase |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
